Literature DB >> 16190884

Differential expression of the homeobox gene Pitx3 in midbrain dopaminergic neurons.

Tatiana M Korotkova1, Alexei A Ponomarenko, Helmut L Haas, Olga A Sergeeva.   

Abstract

The transcription factor Pitx3 is expressed selectively in the midbrain and regulates the differentiation and survival of dopaminergic neurons. Lack of this factor results in a degeneration similar to that seen in Parkinson's disease. We have studied the pattern and the level of expression of Pitx3 in dopaminergic neurons of 3- to 4-week-old Wistar rats. We report Pitx3 expression in almost all dopaminergic substantia nigra (SN) and ventral tegmental area (VTA) neurons. It is coexpressed with the neuroprotective marker calbindin (CB) in a larger population of VTA (43%) than SN (16%) dopaminergic neurons. The level of Pitx3 mRNA, determined by semiquantitative RT-PCR, is approximately 6x higher in VTA than in SN single neurons. In the VTA but not in SN the level of Pitx3 is associated with the presence of CB: in CB-positive neurons the expression of Pitx3 mRNA is 3.6x higher than in CB-negative cells. CB is expressed in a larger population of VTA than SN neurons and the relative level of CB expression is 4x higher in VTA than in SN. A higher Pitx3 expression level and higher coexpression of Pitx3 and CB in VTA than in SN neurons may contribute to the different vulnerability of these dopaminergic nuclei to neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16190884     DOI: 10.1111/j.1460-9568.2005.04327.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  8 in total

1.  Designer receptors: therapeutic adjuncts to cell replacement therapy in Parkinson's disease.

Authors:  Elena M Vazey; Gary Aston-Jones
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

2.  Conditional, inducible gene silencing in dopamine neurons reveals a sex-specific role for Rit2 GTPase in acute cocaine response and striatal function.

Authors:  Carolyn G Sweeney; Patrick J Kearney; Rita R Fagan; Lindsey A Smith; Nicholas C Bolden; Rubing Zhao-Shea; Iris V Rivera; Jenya Kolpakova; Jun Xie; Guangping Gao; Andrew R Tapper; Gilles E Martin; Haley E Melikian
Journal:  Neuropsychopharmacology       Date:  2019-07-05       Impact factor: 7.853

3.  Excitation of histaminergic tuberomamillary neurons by thyrotropin-releasing hormone.

Authors:  Regis Parmentier; Sergej Kolbaev; Boris P Klyuch; David Vandael; Jian-Sheng Lin; Oliver Selbach; Helmut L Haas; Olga A Sergeeva
Journal:  J Neurosci       Date:  2009-04-08       Impact factor: 6.167

Review 4.  Development and function of the midbrain dopamine system: what we know and what we need to.

Authors:  G B Bissonette; M R Roesch
Journal:  Genes Brain Behav       Date:  2015-11-08       Impact factor: 3.449

Review 5.  Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.

Authors:  Angela Anderegg; Jean-Francois Poulin; Rajeshwar Awatramani
Journal:  FEBS Lett       Date:  2015-10-23       Impact factor: 4.124

Review 6.  Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update.

Authors:  Lars Brichta; Paul Greengard
Journal:  Front Neuroanat       Date:  2014-12-15       Impact factor: 3.856

7.  Age-mediated transcriptomic changes in adult mouse substantia nigra.

Authors:  Lin Gao; María Hidalgo-Figueroa; Luis M Escudero; Juan Díaz-Martín; José López-Barneo; Alberto Pascual
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

8.  Long-Term Effects of Maternal Deprivation on the Volume of Dopaminergic Nuclei and Number of Dopaminergic Neurons in Substantia Nigra and Ventral Tegmental Area in Rats.

Authors:  Slobodan Kapor; Milan Aksić; Laslo Puškaš; Marin Jukić; Joko Poleksić; Filip Milosavljević; Suncica Bjelica; Branislav Filipović
Journal:  Front Neuroanat       Date:  2020-10-23       Impact factor: 3.856

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.